Top 10 Companies in the Global Nystatin Market (2026): Market Leaders Powering Global Antifungal Solutions

MARKET INSIGHTS

The Global Nystatin market size was valued at USD 215.4 million in 2025. The market is projected to grow from USD 226.5 million in 2026 to USD 312.8 million by 2034, exhibiting a CAGR of 4.7% during the forecast period.

Global Nystatin Market – View in Detailed Research Report

Nystatin is a polyene antifungal medication discovered in the 1950s, which remains a cornerstone in the treatment of fungal infections caused by Candida species. It functions by binding to ergosterol, a key component of fungal cell membranes, creating pores that lead to cell death. Because it is poorly absorbed from the gastrointestinal tract, its primary applications are for topical use on the skin and for localized infections of the oral cavity (oral thrush) and the intestinal tract. It is available in various formulations, including creams, ointments, powders, and oral suspensions.

The market growth is driven by the persistent and high Global prevalence of fungal infections, particularly candidiasis. The increasing population of immunocompromised individuals, such as those with HIV/AIDS, undergoing chemotherapy, or receiving organ transplants, who are highly susceptible to opportunistic fungal infections, is a significant driver. Furthermore, rising healthcare awareness and improved diagnostic capabilities contribute to market expansion. However, the market faces challenges from the availability of alternative antifungal agents and the emergence of resistance. Key players like Teva Pharmaceutical Industries Ltd., Pfizer Inc., and Glenmark Pharmaceuticals Ltd. maintain a strong presence with their established Nystatin product portfolios.

🔟 1. Pure Chemistry Scientific

Headquarters: New Jersey, USA
Key Offering: USP Grade Nystatin API for pharmaceutical and veterinary use

Pure Chemistry Scientific is a leading supplier of high‑purity antifungal APIs, specializing in USP‑grade Nystatin for topical and oral formulations. Their state‑of‑the‑art fermentation platform ensures consistent potency and purity, meeting stringent regulatory standards across North America and Europe.

Sustainability & Growth Initiatives:

• Investing in green fermentation processes to reduce CO₂ emissions.
• Expanding capacity in the U.S. to meet growing demand for topical antifungals.
• Partnering with academic institutions for research‑grade Nystatin.

9️⃣ 2. BOC Sciences

Headquarters: New York, USA
Key Offering: USP Grade and Research Grade Nystatin, specialty formulations

BOC Sciences delivers high‑quality Nystatin APIs with a focus on purity and batch consistency. Their vertically integrated manufacturing allows rapid scale‑up for both commercial and custom research applications.

Sustainability & Growth Initiatives:

• Adopting renewable energy sources across production sites.
• Launching a new line of low‑cost research grade APIs.
• Strategic collaborations with biotech firms for novel delivery systems.

8️⃣ 3. LGM Pharma

Headquarters: New York, USA
Key Offering: USP Grade Nystatin for dermatology and oral care products

LGM Pharma supplies high‑purity Nystatin to major dermatology and oral health manufacturers. Their focus on quality assurance and rapid regulatory approval positions them as a preferred partner for new product launches.

Sustainability & Growth Initiatives:

• Implementing waste‑reduction protocols in fermentation processes.
• Expanding distribution to emerging markets in Asia‑Pacific.
• Investing in R&D for liposomal Nystatin formulations.

7️⃣ 4. Toronto Research Chemicals

Headquarters: Toronto, Canada
Key Offering: Research Grade Nystatin for laboratories and small‑scale manufacturers

Toronto Research Chemicals offers a versatile portfolio of research‑grade APIs, including Nystatin, supporting academic and industrial research in antifungal therapeutics.

Sustainability & Growth Initiatives:

• Optimizing raw‑material sourcing to reduce supply chain risk.
• Providing custom synthesis services for niche applications.
• Collaborating with universities on antifungal drug discovery.

6️⃣ 5. Waterstone Technology

Headquarters: New Jersey, USA
Key Offering: USP Grade Nystatin and other specialty APIs

Waterstone Technology supplies high‑purity APIs to the pharmaceutical industry, with a strong emphasis on quality control and regulatory compliance.

Sustainability & Growth Initiatives:

• Adopting water‑efficient fermentation systems.
• Expanding capacity to support growing demand for topical antifungals.
• Developing eco‑friendly packaging solutions.

5️⃣ 6. HBCChem

Headquarters: Shenzhen, China
Key Offering: USP Grade Nystatin for domestic and export markets

HBCChem produces cost‑effective, high‑quality Nystatin APIs, leveraging China’s advanced biopharmaceutical infrastructure to supply both domestic and international customers.

Sustainability & Growth Initiatives:

• Implementing renewable energy in manufacturing facilities.
• Strengthening quality assurance to meet global standards.
• Expanding product line to include veterinary formulations.

4️⃣ 7. 3B Scientific

Headquarters: Shenzhen, China
Key Offering: Research Grade Nystatin and other specialty APIs

3B Scientific focuses on delivering high‑quality research APIs, including Nystatin, to academic and biotech companies worldwide.

Sustainability & Growth Initiatives:

• Optimizing raw‑material sourcing for cost efficiency.
• Collaborating with global partners on novel drug delivery.
• Enhancing quality control through automated analytics.

3️⃣ 8. Beijing NuoqiYa Biotechnology

Headquarters: Beijing, China
Key Offering: USP Grade and Research Grade Nystatin for research and commercial use

Beijing NuoqiYa Biotechnology supplies high‑purity Nystatin APIs, supporting both research institutions and pharmaceutical manufacturers.

Sustainability & Growth Initiatives:

• Adopting clean‑lab practices to reduce environmental footprint.
• Expanding production capacity to meet rising demand in Asia‑Pacific.
• Investing in R&D for novel antifungal formulations.

2️⃣ 9. J & K SCIENTIFIC

Headquarters: Shenzhen, China
Key Offering: Research Grade Nystatin and other specialty APIs

J & K SCIENTIFIC provides a broad range of research‑grade APIs, including Nystatin, to support scientific studies and product development.

Sustainability & Growth Initiatives:

• Improving waste‑management protocols.
• Partnering with universities for antifungal research.
• Enhancing supply‑chain resilience.

1️⃣ 10. BeiJing Hwrk Chemicals

Headquarters: Beijing, China
Key Offering: USP Grade Nystatin for pharmaceutical and veterinary markets

BeiJing Hwrk Chemicals delivers high‑purity Nystatin APIs, focusing on both commercial pharmaceutical and veterinary applications.

Sustainability & Growth Initiatives:

• Investing in renewable energy for manufacturing.
• Expanding product line to include flavored veterinary formulations.
• Strengthening quality assurance to meet international standards.

Download FREE Sample Report: Global Nystatin Market – View in Detailed Research Report

Get Full Report: Global Nystatin Market – View in Detailed Research Report

🌍 Outlook: The Future of Global Nystatin Market

The Global Nystatin market is poised for sustained growth driven by rising prevalence of candidiasis, expanding immunocompromised populations, and increasing adoption of topical and oral formulations. Regulatory support for USP‑grade APIs and ongoing R&D for novel delivery systems, such as liposomal and nano‑encapsulated Nystatin, will further accelerate market expansion. The Asia‑Pacific region will continue to be the fastest‑growing market, fueled by urbanization, improved healthcare infrastructure, and cost‑effective generics. North America remains the largest market, driven by advanced healthcare systems and high prescription volumes for dermatology and oral care products.

📈 Future Trends Shaping the Nystatin Landscape

• Emergence of combination therapies with corticosteroids to enhance efficacy.
• Growth of veterinary applications, especially flavored formulations for livestock and pets.
• Increased focus on patient compliance, leading to development of palatable oral suspensions.
• Expansion of tele‑medicine platforms to improve diagnosis and prescription of antifungal treatments.
• Investments in green manufacturing and sustainability across the supply chain.